| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.99B | +13.1% |
| R&D Expense | $211.2M | +9.1% |
| SG&A Expense | $2.55B | +4.1% |
| Operating Income | $2.42B | +19.6% |
| Interest Expense | $223.5M | -4.4% |
| Pre-tax Income | $2.17B | +21.3% |
| Income Tax | $375.9M | +12.7% |
| Net Income | $1.76B | +23.4% |
| EPS (Basic) | $7.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.22B | -43.5% |
| Accounts Receivable | $2.78B | +14.4% |
| Inventory | $1.99B | +30.2% |
| Current Assets | $6.38B | -1.4% |
| Total Assets | $18.08B | +0.1% |
| Current Liabilities | $5.69B | +19.7% |
| Long-term Debt | $4.84B | -0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.50B | -5.3% |
| Capital Expenditures | $291.8M | +30.9% |
| Investing Cash Flow | -$540.4M | +1.0% |
| Financing Cash Flow | -$1.85B | +12.9% |
| Free Cash Flow | $1.21B | -11.2% |
| +26.7% |
| EPS (Diluted) | $7.48 | +27.4% |
| Total Liabilities |
| $11.98B |
| +1.6% |
| Stockholders' Equity | $6.09B | -2.7% |